Nelson Isabel

Nelson F. Isabel serves as the Chief Financial Officer of Ironshore Therapeutics Inc. and has been a pharmaceutical industry executive for 18 years. Prior to joining Ironshore, Mr. Isabel spent seven years at Biovail Corporation (now Bausch Health), Canada’s largest publicly traded pharmaceutical company, where he served on its Finance Leadership Team and was responsible for all investor relations activities. Prior to Biovail, Mr. Isabel was an equity research analyst covering the North American healthcare industry with CIBC World Markets and with Desjardins Securities.​​​​​​​

Mr. Isabel has a B.Sc. in Biology (Experimental Animal Physiology) and a Master of Business Administration from the Schulich School of Business in Toronto. He has been a CFA Charterholder since 2002.